We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Online Platform Improves Proton Therapy Delivery

By HospiMedica International staff writers
Posted on 03 Nov 2021
A new interactive platform enables proton therapy providers to share materials and resources, as well as discussion forums with other users.

Ion Beam Applications (IBA; Louvain-La-Neuve, Belgium) Campus is dedicated to help clinicians and researchers in proton therapy enhance existing and learn new skills for the benefit of patients. More...
Campus visitors will also have access to IBA’s network of proton therapy experts, who have deep knowledge and experience in working with the IBA state-of-the-art Proteus systems. Campus was presented at the annual American Society for Radiation Oncology (ASTRO) meeting, held during October 2021 in Chicago (IL, USA).

The IBA Proteus ONE is a single-room configuration consisting of an accelerator, a direct beam line, and a compact gantry. It is equipped with cone beam CT (CBCT), stereoscopic imaging, and pencil beam scanning (PBS) technologies, which allow the treatment of a diverse range of ocular tumors, central nervous system (CNS) cancers, head and neck malignancies, thoracic tumors, and abdominal and pelvic malignancies. IBA also offers Proteus PLUS, a made-to-measure, image-guided, intensity-modulated, proton beam technology system.

“An online platform dedicated solely to proton therapy will allow users to access and utilize resources at the click of a button,” said Professor Hans Langendijk, MD, PhD, of UMC Groningen (The Netherlands). “I am excited to learn from IBA’s network of leading experts, as they share their latest findings, with the ultimate goal of improving not only the quality of patient treatment but also the general operations behind our proton therapy centers.”

“Campus will be an invaluable tool to those working within the proton therapy field, particularly those starting out their careers in this dynamic area,” said Professor James Metz, MD, chair of the department of radiation oncology at Penn Medicine (Philadelphia, PA, USA). “Access to educational materials, focused events, and support from IBA’s network of experienced operating centers will be key in allowing users to learn and assist in the advancement of this important technology.”

Proton therapy is a precise form of radiotherapy (RT) that uses charged particles instead of x-rays. It can be a more effective form of treatment than conventional radiotherapy, as it directs RT more precisely, with minimal damage to surrounding tissue. Evidence is growing that protons can be effective in treating a number of cancers, in particular children and young people with brain tumors, for whom it appears to produce fewer side effects such as secondary cancers, growth deformity, hearing loss, and learning difficulties.

Related Links:
Ion Beam Applications


Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Wound Irrigation Solution
Prontosan®
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Noninvasive Imaging Approach Aims to Detect Basal Cell Carcinoma Before It Becomes Visible

Basal cell carcinoma is the most common form of skin cancer and can damage nearby structures such as the nose or eyes when it develops on the face. Diagnosis typically depends on visible skin changes,... Read more

Surgical Techniques

view channel
Image: Associate Professor Menglin Chen studies how the light-sensitive nanoparticles affect living cells. The screen shows calcium being released inside a cell after nanoparticles taken up by the cell are exposed to blue light. Calcium plays an important role in cellular signaling, and the experiment helps the researchers understand how the nanoparticles can translate light into biological activity. (Photo courtesy of Aarhus University, Johanne Holm Jensen)

Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses

Retinitis pigmentosa is a degenerative retinal disorder in which photoreceptors progressively die, reducing visual signals to the brain while leaving surviving inner retinal circuits underused.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.